Inventor
HAQUE TASIR SHAMSUL
US12 patents
Patents
12 patentsUS7417028B2Aug 26, 2008
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions
BRISTOL MYERS SQUIBB CO20 citations91
US10912766B2Feb 9, 2021
[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations83
US11306092B2Apr 19, 2022
Amino indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US11447466B2Sep 20, 2022
Substituted indole compounds useful as inhibitors of TLR7/8/9
BRISTOL MYERS SQUIBB CO3 citations72
US11420973B2Aug 23, 2022
Amide substituted indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10660877B2May 26, 2020
Pyridyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations72
US11420958B2Aug 23, 2022
Aryl and heteroaryl substituted indole compounds
BRISTOL MYERS SQUIBB CO3 citations71
US11672780B2Jun 13, 2023
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations62
US7534763B2May 19, 2009
Sustained release GLP-1 receptor modulators
BRISTOL MYERS SQUIBB CO5 citations59
US12030878B2Jul 9, 2024
Substituted indole ether compounds
BRISTOL MYERS SQUIBB CO0 citations51
US11739098B2Aug 29, 2023
Substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations51
US11878975B2Jan 23, 2024
Substituted indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO0 citations50